Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00524420 · ClinicalTrials.gov registry record · Phase 2

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

A Phase 2 study of Depression and Chronic Pain, sponsored by University of Washington.

Completed
Registry status
Phase 2
Development phase
19
Enrollment target
1
Study location

NCT00524420 is a Phase 2 study of Depression and Chronic Pain that has completed, run by University of Washington. The registered enrollment target is 19 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00524420, a Phase 2 study of Depression and Chronic Pain, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 2
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

While acute pain after surgery or trauma comes on suddenly and lasts for a limited amount of time, chronic pain persists and can continue for months and even years. Repetitive transcranial magnetic stimulation (rTMS) uses a magnetic field to deliver a current to the brain and can affect brain activity. The purpose of this study is to determine the effectiveness of rTMS treatment in reducing chronic widespread pain in women.

Interventions

  • DEVICE Sham rTMS
  • DEVICE rTMS

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2008-02
Est. Completion 2010-12
Phase Phase 2

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT00524420

The ClinicalTrials.gov registry entry for NCT00524420 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Sham rTMS is the first listed.

NCT00524420 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00524420 about?

NCT00524420 is a clinical study titled "Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain". While acute pain after surgery or trauma comes on suddenly and lasts for a limited amount of time, chronic pain persists and can continue for months and even years. Repetitive transcranial magnetic stimulation (rTMS) uses a magnetic field to deliver a current to the brain and can affect brain activi...

What is the current status of trial NCT00524420?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2008-02. Estimated completion is 2010-12.

What conditions does trial NCT00524420 study?

This clinical trial studies the following conditions: Depression, Chronic Pain, Fibromyalgia.

What interventions are being tested in trial NCT00524420?

The interventions under investigation include: Sham rTMS (DEVICE), rTMS (DEVICE).

Who is sponsoring clinical trial NCT00524420?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00524420 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.